37.25
price down icon2.03%   -0.77
after-market Handel nachbörslich: 37.25
loading

Immunocore Holdings Plc Adr Aktie (IMCR) Neueste Nachrichten

pulisher
Jun 05, 2025

Immunocore at Jefferies Global Healthcare Conference: Strong Growth and Promising Trials - Investing.com India

Jun 05, 2025
pulisher
Jun 02, 2025

Wall Street Analysts Think Immunocore (IMCR) Could Surge 65.22%: Read This Before Placing a Bet - sharewise

Jun 02, 2025
pulisher
May 27, 2025

Deutsche Bank sets $65 target on Immunocore stock, rates Buy By Investing.com - Investing.com India

May 27, 2025
pulisher
May 27, 2025

Deutsche Bank sets $65 target on Immunocore stock, rates Buy - Investing.com

May 27, 2025
pulisher
May 25, 2025

Immunocore’s SWOT analysis: biotech firm’s stock faces challenges amid growth - Investing.com

May 25, 2025
pulisher
May 24, 2025

Is it a Good Idea to Invest in Immunocore Stock Right Now? - MSN

May 24, 2025
pulisher
May 17, 2025

Wall Street Analysts See an 114.35% Upside in Immunocore (IMCR): Can the Stock Really Move This High? - MSN

May 17, 2025
pulisher
May 09, 2025

Balance Sheet Dive: Hippo Holdings Inc (HIPO)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

May 09, 2025
pulisher
May 09, 2025

Analyzing Ratios: Symbotic Inc (SYM)’s Financial Story Unveiled - DWinneX

May 09, 2025
pulisher
May 08, 2025

New Strong Buy Stocks for May 8th - The Globe and Mail

May 08, 2025
pulisher
May 07, 2025

Immunocore stock rises as Q1 results top estimates By Investing.com - Investing.com South Africa

May 07, 2025
pulisher
May 07, 2025

Immunocore stock rises as Q1 results top estimates - Investing.com

May 07, 2025
pulisher
May 07, 2025

Immunocore Holdings earnings beat by $0.49, revenue topped estimates - Investing.com

May 07, 2025
pulisher
May 07, 2025

Compared to Estimates, Immunocore (IMCR) Q1 Earnings: A Look at Key Metrics - Yahoo Finance

May 07, 2025
pulisher
May 06, 2025

ESPR's Q1 Earnings Miss Estimates, Revenues Beat, Stock Down - Barchart.com

May 06, 2025
pulisher
May 06, 2025

AXSM Q1 Loss Narrower Than Expected, Auvelity Drives Revenues Y/Y - The Globe and Mail

May 06, 2025
pulisher
May 02, 2025

Agios' Q1 Loss Narrower Than Expected, Revenues Lag Estimates - Barchart.com

May 02, 2025
pulisher
Apr 30, 2025

Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y - Barchart.com

Apr 30, 2025
pulisher
Apr 30, 2025

Wall Street Analysts Think Immunocore (IMCR) Could Surge 107.45%: Read This Before Placing a Bet - Yahoo Finance

Apr 30, 2025
pulisher
Apr 07, 2025

Mizuho cuts Immunocore stock price target to $33 from $38 - Investing.com

Apr 07, 2025
pulisher
Apr 04, 2025

Immunocore stock hits 52-week low at $27.19 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

Immunocore stock hits 52-week low at $27.19 amid market challenges - Investing.com

Apr 04, 2025
pulisher
Mar 28, 2025

Do investors need to be concerned about Immunocore Holdings plc ADR (IMCR)? - US Post News

Mar 28, 2025
pulisher
Mar 22, 2025

Immunocore (IMCR) Moves 6.0% Higher: Will This Strength Last? - MSN

Mar 22, 2025
pulisher
Mar 19, 2025

Immunocore holdings sees $23.99 million in stock purchases by Baker Bros - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 17, 2025

Immunocore amends senior notes indenture, files prospectus - Investing.com India

Mar 17, 2025
pulisher
Mar 17, 2025

Immunocore amends senior notes indenture, files prospectus By Investing.com - Investing.com South Africa

Mar 17, 2025
pulisher
Mar 12, 2025

H.C. Wainwright maintains $100 target on Immunocore stock - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Immunocore’s SWOT analysis: biotech firm’s stock outlook amid HIV and cancer drug progress - Investing.com

Mar 12, 2025
pulisher
Mar 11, 2025

BTIG maintains Immunocore stock Buy rating, $91 target - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Immunocore stock hits 52-week low at $27.59 amid market challenges - Investing.com

Mar 11, 2025
pulisher
Mar 10, 2025

Immunocore reports promising HIV trial results By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 10, 2025

Immunocore reports promising HIV trial results - Investing.com India

Mar 10, 2025
pulisher
Mar 10, 2025

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025 - GlobeNewswire Inc.

Mar 10, 2025
pulisher
Mar 06, 2025

Immunocore at TD Cowen Conference: Strategic Growth and Innovation - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

Immunocore at TD Cowen Conference: Strategic Growth and Innovation By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Feb 28, 2025

PBYI Stock Rises as Q4 Earnings & Sales Outpace EstimatesFebruary 28, 2025 - Zacks Investment Research

Feb 28, 2025
pulisher
Feb 26, 2025

Earnings call transcript: Immunocore Holdings Q4 2024 misses EPS - Investing.com

Feb 26, 2025
pulisher
Feb 26, 2025

Immunocore Holdings earnings missed by $0.23, revenue fell short of estimates - Investing.com

Feb 26, 2025
pulisher
Feb 26, 2025

United Therapeutics Stock Down Despite Q4 Earnings & Sales Beat - Yahoo Finance

Feb 26, 2025
pulisher
Feb 20, 2025

Bausch Health Beats on Q4 Earnings and Revenues, Xifaxan Boosts Sales - Yahoo Finance

Feb 20, 2025
pulisher
Feb 18, 2025

Immunocore Gears Up to Report Q4 Earnings: Is a Beat in Store? - MSN

Feb 18, 2025
pulisher
Feb 17, 2025

A stock that deserves closer examination: Empresa Distribuidora y Comercial Norte S.A. ADR (EDN) - US Post News

Feb 17, 2025
pulisher
Feb 17, 2025

I-Mab ADR (IMAB) stock analysis: A simple moving average approach - US Post News

Feb 17, 2025
pulisher
Feb 17, 2025

A closer look at Inhibrx Biosciences Inc (INBX)’s stock price trends - US Post News

Feb 17, 2025
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):